Cytiva Xcellerex Automated Perfusion System (APS)

Monday, 21 September, 2020 | Supplied by: Global Life Sciences Solutions


Cytiva’s Xcellerex Automated Perfusion System (APS) is designed to support the biotech industry’s move to continuous manufacturing, simplifying processes and reducing risk when intensifying upstream operations.

In cell cultivation using perfusion, media is continuously fed and product harvested. This increases output compared to traditional batch or fed batch methods, yet perfusion processes still involve substantial manual work and risk. Overcoming this challenge by simplifying and automating upstream operations would alleviate bottlenecks further along the perfusion process, increasing overall productivity and output.

Xcellerex APS integrates with Cytiva’s Xcellerex XDR bioreactors for continuous upstream bioprocessing operations. The system’s automation capabilities include automated filter switching, liquid management and cell bleed, reducing risk for human error and increasing process robustness.

Online: www.cytivalifesciences.com/en/au
Phone: 1800 150 522
Related Products

BIOVIA Discovery Studio software as a service and on-prem application

BIOVIA Discovery Studio is a powerful software suite widely used for 3D molecular modelling,...

Seer Proteograph automated platform for proteomic studies

Seer has released what it describes as the first and only automated platform for proteomic...

Sartorius Biostat STR Generation 3 for Emerson's DeltaV

The Biostat STR Generation 3 for Emerson's DeltaV is a pre-engineered solution that delivers...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd